Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy

por Hézode, Christophe, Kwo, Paul, Sperl, Jan, Hwang, Peggy, Long, Jianmin, Talwani, Rohit, Robertson, Michael N, Haber, Barbara A
Publicado 2019

Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older

por Flamm, Steven, Peng, Cheng-Yuan, Shibolet, Oren, Nahass, Ronald, Hwang, Peggy, Barr, Eliav, Robertson, Michael N., Haber, Barbara A.
Publicado 2019

Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants

por Quirk, Erin K., Brown, Elizabeth L., Leavitt, Randi Y., Mogg, Robin, Mehrotra, Devan V., Evans, Robert K., DiNubile, Mark J., Robertson, Michael N.
Publicado 2014

Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial

por Zhdanov, Konstantin, Isakov, Vasily, Burnevich, Eduard, Kizhlo, Svetlana, Bakulin, Igor, Pokrovsky, Vadim, Liang, Liwen, Hwang, Peggy, Talwani, Rohit, Haber, Barbara A, Robertson, Michael N
Publicado 2020

Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis C infection

por Reau, Nancy, Robertson, Michael N., Feng, Hwa‐Ping, Caro, Luzelena, Yeh, Wendy W., Nguyen, Bach‐Yen T., Wahl, Janice, Barr, Eliav, Hwang, Peggy, Klopfer, Stephanie O.
Publicado 2017

Baseline Ad5 serostatus does not predict Ad5-HIV vaccine-induced expansion of Ad-specific CD4+ T-cells

por Hutnick, Natalie A., Carnathan, Diane G., Dubey, Sheri A., Cox, Kara, Kierstead, Lisa, Ratcliffe, Sarah J., Robertson, Michael N., Casimiro, Danilo R., Ertl, Hildegund C.J., Betts, Michael R.
Publicado 2009

HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1

por Hertz, Tomer, Ahmed, Hasan, Friedrich, David P., Casimiro, Danilo R., Self, Steven G., Corey, Lawrence, McElrath, M. Juliana, Buchbinder, Susan, Horton, Helen, Frahm, Nicole, Robertson, Michael N., Graham, Barney S., Gilbert, Peter
Publicado 2013

Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Tr...

por Molina, Jean-Michel, Yazdanpanah, Yazdan, Afani Saud, Alejandro, Bettacchi, Christopher, Chahin Anania, Carolina, Klopfer, Stephanie O., Grandhi, Anjana, Eves, Karen, Hepler, Deborah, Robertson, Michael N., Hwang, Carey, Hanna, George J., Correll, Todd
Publicado 2022

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8(+) T Cells without Altering Memory Phenotype or Functionality

por Hutnick, Natalie A., Carnathan, Diane G., Dubey, Sheri A., Cox, Kara S., Kierstead, Lisa, Makadonas, George, Ratcliffe, Sarah J., Lasaro, Marcio O., Robertson, Michael N., Casimiro, Danilo R., Ertl, Hildegund C. J., Betts, Michael R.
Publicado 2010

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection

por Matthews, Randolph P., Zang, Xiaowei, Barrett, Stephanie E., Koynov, Athanas, Goodey, Adrian, Heimbach, Tycho, Weissler, Vanessa L., Leyssens, Carlien, Reynders, Tom, Xu, Zhiqing, Rottey, Sylvie, Vargo, Ryan, Robertson, Michael N., Stoch, S. Aubrey, Iwamoto, Marian
Publicado 2023

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

por Kumada, Hiromitsu, Suzuki, Yoshiyuki, Karino, Yoshiyasu, Chayama, Kazuaki, Kawada, Norifumi, Okanoue, Takeshi, Itoh, Yoshito, Mochida, Satoshi, Toyoda, Hidenori, Yoshiji, Hitoshi, Takaki, Shintaro, Yatsuzuka, Naoyoshi, Yodoya, Etsuo, Iwasa, Takashi, Fujimoto, Go, Robertson, Michael N., Black, Stuart, Caro, Luzelena, Wahl, Janice
Publicado 2016

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans

por O’Brien, Kara L., Liu, Jinyan, King, Sharon L., Sun, Ying-Hua, Schmitz, Joern E., Lifton, Michelle A., Hutnick, Natalie A., Betts, Michael R., Dubey, Sheri A., Goudsmit, Jaap, Shiver, John W., Robertson, Michael N., Casimiro, Danilo R., Barouch, Dan H.
Publicado 2009

Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial

por Wei, Lai, Jia, Ji Dong, Duan, Zhong Ping, Wang, Fu Sheng, Niu, Jun Qi, Xie, Wen, Huang, Wen Xiang, Zhang, Ming Xiang, Huang, Yan, Wang, Mao Rong, Wu, Shan Ming, Zhao, Ying Ren, Jia, Zhan Sheng, Zhao, Xu Min, Mu, Sheng Mei, Liang, Li Wen, Wang, Zaiqi, Puenpatom, Amy, Hwang, Peggy, Robertson, Michael N., Ingravallo, Paul, Asante‐Appiah, Ernest, Wei, Bo, Evans, Barbara, Hanna, George J., Talwani, Rohit
Publicado 2020

Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial

por Rolland, Morgane, Tovanabutra, Sodsai, deCamp, Allan C., Frahm, Nicole, Gilbert, Peter B., Sanders-Buell, Eric, Heath, Laura, Magaret, Craig A., Bose, Meera, Bradfield, Andrea, O’Sullivan, Annemarie, Crossler, Jacqueline, Jones, Teresa, Nau, Marty, Wong, Kim, Zhao, Hong, Raugi, Dana N., Sorensen, Stephanie, Stoddard, Julia N., Maust, Brandon S., Deng, Wenjie, Hural, John, Dubey, Sheri, Michael, Nelson L., Shiver, John, Corey, Lawrence, Li, Fusheng, Self, Steve G., Kim, Jerome, Buchbinder, Susan, Casimiro, Danilo R., Robertson, Michael N., Duerr, Ann, McElrath, M. Juliana, McCutchan, Francine E., Mullins, James I.
Publicado 2011